Irkutsk, Irkutsk region, Russian Federation
Bleeding in pregnancy, childbirth and the postpartum period is one of the leading causes of maternal morbidity and mortality worldwide. There is no doubt that obstetric bleeding demands the development of improved methods for its diagnostics and treatment. We assessed the effectiveness of the treatment strategy for massive postpartum hemorrhage (PPH) with preservation of reproductive function, applied in the Perinatal Center of Irkutsk. We performed a retrospective analysis of 24 delivery cases, complicated by massive bleeding and successfully treated with preservation of reproductive organs. The massive nature of bleeding (≥ 30 % of blood volume) was registered in 15 (62.5 %) cases, mild (≥ 20 % but ≤ 30 % of blood volume) – in 9 (37.5 %). Emergency operative delivery (cesarean section) was performed in 40 % of massive PPH cases and in 66.7 % of mild PPH cases. Uterotonic drugs were used in all PPH cases. When analyzing complex mechanical methods of PPH arrest, we noticed that in 20 % of cases balloon tamponade was used. In 33.3 % of mild PPH cases, balloon tamponade with great vessels ligation was performed. Thus, the most effective method was balloon tamponade coupled with Baksheev forceps and early surgical hemostasis. All in all, prevention of hemorrhage in risk groups and early fluid and surgical therapy, and also administration of uterotonic drugs in PPH treatment not only provide a hemostatic effect but also preserve reproductive function.
prevention, postpartum hemorrhage, infusion, surgical hemostasis
1. WHO (2014). The top 10 causes of death. Fact sheet [10 vedushchikh prichin smerti v mire. Informatsionnyy byulleten’], (310).
2. Кramarskiy VA (2012). Tactical solutions of some obstetric problems [Takticheskie resheniya nekotorykh akusherskikh problem], 235.
3. Kurtser MA, Kunakova YY, Breslav IY (2015). Massive obstetric bleedings. Modern approaches to diagnostics and treatment [Massivnye akusherskie krovotecheniya. Sovremennye podkhody k diagnostike i lecheniyu]. Plod i novorozhdennyy kak patsienty, 1033-1049.
4. Prevention and therapy of massive blood loss in obstetrics. Health technology (2010) [Profilaktika i terapiya massivnoy krovopoteri v akusherstve. Meditsinskaya tekhnologiya]. N 2010/141 d. d. 29.04.2010, 17.
5. Radzinskiy VE (2010). The formulary of medicines in obstetrics and gynecology [Formulyar lekarstvennykh sredstv v akusherstve i ginekologii], 791.
6. Kulakov VI, Serova VN (eds.) (2005). Rational pharmacotherapy in obstetrics and gynecology [Ratsional’naya farmakoterapiya v akusherstve i ginekologii], 720.
7. Anderson J, Etches D, Smith D (2000). Postpartum haemorrhage. Advanced Life Support In Obstetrics (ALSO) provider course manual (eds. J.R. Damos, S.H. Eisinger), 1-15.
8. Foley MR, Strong TN Jr., Garite TJ (2010). Obstetrics Intensive Care Manual, 3rd ed., 369.
9. Magann EF, Evans S, Hutchinson M, Collins R, Morrison JC (2005). Postpartum hemorrhage after cesarean delivery: an analysis of risk factors. S. Med. J., (98), 681-685.
10. Rouse DJ, Leindecker S, Landon M, Bloom SL, Varner MW, Moawad AH, Spong CY, Caritis SN, Harper M, Wapner RJ, Sorokin Y, Miodovnik M, O’Sullivan MJ, Sibai BM, Langer O (2005). The MFMU Cesarean Registry: uterine atony after primary cesarean delivery. Am. J. Obstet. Gynecol., (193), 1056-1060.
11. Silver RM, Landon MB, Rouse DJ, Leveno KJ, Spong CY, Thom EA, Moawad AH, Caritis SN, Harper M, Wapner RJ, Sorokin Y, Miodovnik M, Carpenter M, Peaceman AM, O’Sullivan MJ, Sibai B, Langer O, Thorp JM, Ramin SM, Mercer BM (2006). Maternal morbidity associated with multiple repeat cesarean deliveries. Obstet. Gynekol., 107 (6), 1226-1232.
